Travaux scientifiques

Doç. Dr. Yasin Kutlu

54 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. 1. KUTLU, Y., & BİLİCİ, A. (2022). İmmünoterapilerin Endokrin Yan Etkileri ve Yönetimi. Turkiye Klinikleri Medical Oncology-Special Topics, 15(1), 30-36.

    Source : page de profil sur medipol.com.tr

  2. 2. KUTLU, Y., & ÖLMEZ, Ö. F. (2022). İmmünoterapilerin Karaciğer Yan Etkileri ve Yönetimi. Turkiye Klinikleri Medical Oncology-Special Topics, 15(1), 17-23.

    Source : page de profil sur medipol.com.tr

  3. 5. Oven, B. B., Okten, I. N., Bilici, A., Yasin, A. I., Koca, S., Yuzugullu, E., ... & Gumus, M. (2024). Is Clinical Risk Score a Useful Predictive Marker of Early Recurrence Among Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors?. Eurasian Journal of Medical Investigation, 8(2).

    Source : page de profil sur medipol.com.tr

  4. 6. Akdogan, O., Sutcuoglu, O., Tunali, D., Divrikoglu, D., Gurbuz, A. F., & Kutlu, Y. (2024). Multicenter Real-World Experience from the Turkish Oncology Group: Sotorasib in KRAS G12C-Mutated NSCLC. Eurasian Journal of Medical Investigation, 8(4), 274.

    Source : page de profil sur medipol.com.tr